Noticias de ABBV_US
Noticias del mercado
Últimas noticias sobre ABBV_US — 334 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
BeiGene Can’t Toss AbbVie Trade Secrets Suit Over Cancer Therapy
AbbVie stock (US00287Y1091): Q1 earnings beat and guidance raise drive 3.1% gain
AbbVie stock (US00287Y1091): Rises 3.3% on 2026 outlook and AGM results
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
A Look At AbbVie (ABBV) Valuation After New Immunology Data And Upgraded 2026 Earnings Outlook
AbbVie Inc. 8-K SEC Filing May 2026: Common Stock and Senior Notes Registered on NYSE
AbbVie Inc. (ABBV) Announces Results of 2026 Annual Meeting of S
AbbVie Inc. (ABBV) Announces Results of 2026 Annual Meeting of S
AbbVie Inc (ABBV) Stock Up 3.1% and Still Undervalued -- GF Score: 86/100
AbbVie Inc (ABBV) Stock Up 3.1% and Still Undervalued -- GF Score: 86/100
[Form 4] AbbVie Inc. Insider Trading Activity
[8-K] AbbVie Inc. Reports Material Event
AbbVie Inc. (NYSE:ABBV) es una de las mejores acciones de atención médica para comprar a largo plazo. AbbVie Inc.
Why AbbVie Inc. (ABBV) is One of the Best Healthcare Stocks to Buy for the Long Term
AbbVie (NYSE: ABBV) director gains 1,118-share equity award
AbbVie Inc. stock outperforms competitors on strong trading day
Top Stock Reports for NVIDIA, Mastercard & AbbVie
Top Stock Reports for NVIDIA, Mastercard & AbbVie
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow
Página 1 de 17
